BIOT.L vs. LDGL.L

Last updated Jul 16, 2026

BIOT.L (L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF) and LDGL.L (L&G Global Quality Dividends UCITS ETF USD Distributing) are both exchange-traded funds - BIOT.L is a Health & Biotech Equities fund tracking the Solactive Pharma Breakthrough Value Index Net Total Return, while LDGL.L is a Global Equity Income fund tracking the FTSE Developed All Cap Dividend Growth with Quality Index. Both are passively managed. A 0.52 correlation means they provide meaningful diversification when combined. BIOT.L charges 0.49%/yr vs 0.29%/yr for LDGL.L.

Performance

BIOT.L vs. LDGL.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L) and L&G Global Quality Dividends UCITS ETF USD Distributing (LDGL.L). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

BIOT.L

• 1D: 0.31%
• 1M: 7.79%
• 6M: 7.56%
• YTD: 8.27%
• 1Y: 33.81%
• 3Y*: 10.20%
• 5Y*: 2.83%
• 10Y*: —

LDGL.L

• 1D: 0.00%
• 1M: 0.54%
• 6M: 11.10%
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BIOT.L vs. LDGL.L - Yearly Performance Comparison

	2026 (YTD)
BIOT.L L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF	5.10%
LDGL.L L&G Global Quality Dividends UCITS ETF USD Distributing	12.26%

Correlation

The correlation between BIOT.L and LDGL.L is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jan 12, 2026	0.52

Return for Risk

BIOT.L vs. LDGL.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIOT.L

BIOT.L Risk / Return Rank: 67
BIOT.L Sharpe Ratio Rank: 63
BIOT.L Sortino Ratio Rank: 64
BIOT.L Omega Ratio Rank: 55
BIOT.L Calmar Ratio Rank: 83
BIOT.L Martin Ratio Rank: 70

LDGL.L

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIOT.L vs. LDGL.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L) and L&G Global Quality Dividends UCITS ETF USD Distributing (LDGL.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BIOT.L	LDGL.L	Difference
Sharpe ratio: Return per unit of total volatility	1.67	—	—
Sortino ratio: Return per unit of downside risk	2.39	—	—
Omega ratio: Gain probability vs. loss probability	1.28	—	—
Calmar ratio: Return relative to maximum drawdown	3.52	—	—
Martin ratio: Return relative to average drawdown	10.12	—	—

Drawdowns

BIOT.L vs. LDGL.L - Drawdown Comparison

The maximum BIOT.L drawdown since its inception was -34.44%, which is greater than LDGL.L's maximum drawdown of -9.46%. Use the drawdown chart below to compare losses from any high point for BIOT.L and LDGL.L.

Drawdown Indicators

	BIOT.L	LDGL.L	Difference
Max Drawdown Largest peak-to-trough decline	-34.44%	-9.46%	-24.98%
Max Drawdown (1Y) Largest decline over 1 year	-9.55%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-19.91%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-33.80%	—	—
Current Drawdown Current decline from peak	-5.72%	0.00%	-5.72%
Average Drawdown Average peak-to-trough decline	-13.31%	-2.37%	-10.94%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.33%	—	—

Volatility

Volatility by Period

	BIOT.L	LDGL.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.08%	—	—
Volatility (6M) Calculated over the trailing 6-month period	15.54%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	20.18%	14.29%	+5.89%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.62%	14.29%	+4.33%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.50%	14.29%	+5.21%

BIOT.L vs. LDGL.L - Expense Ratio Comparison

BIOT.L has a 0.49% expense ratio, which is higher than LDGL.L's 0.29% expense ratio.

Dividends

BIOT.L vs. LDGL.L - Dividend Comparison

BIOT.L has not paid dividends to shareholders, while LDGL.L's dividend yield for the trailing twelve months is around 1.60%.

Position	TTM
BIOT.L L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF	0.00%
LDGL.L L&G Global Quality Dividends UCITS ETF USD Distributing	1.60%

Frequently Asked Questions

Can I hold both BIOT.L and LDGL.L in my portfolio?

BIOT.L and LDGL.L have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, BIOT.L or LDGL.L?

On fees, LDGL.L is cheaper at 0.29% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, BIOT.L or LDGL.L?

LDGL.L is cheaper with a 0.29% expense ratio, compared with 0.49% for BIOT.L.

What is the main difference between BIOT.L and LDGL.L?

BIOT.L is categorized as Health & Biotech Equities, while LDGL.L is Global Equity Income. BIOT.L tracks Solactive Pharma Breakthrough Value Index Net Total Return, while LDGL.L tracks FTSE Developed All Cap Dividend Growth with Quality Index. Their fees differ too: 0.49% for BIOT.L and 0.29% for LDGL.L.